The pathogenesis of human T-cell lymphotropic virus type I (HTLV-I) in adul
t T-cell leukemia/lymphoma (ATL) and HTLV-I associated myelopathy/tropical
spastic paraparesis (HAM/TSP) is poorly understood. We prospectively follow
ed up and evaluated the virologic correlates of infection in transfusion re
cipients after seroconversion, in asymptomatic carriers, and in ATL and HAM
/TSP patients. Proviral DNA levels (copies/10(5) lymphocytes) were determin
ed by real-time automated polymerase chain reaction and antibody titers by
endpoint dilution by use of an HTLV-I enzyme-linked immunoassay, In early i
nfection, proviral load was initially elevated (median, 212 copies/10(5) ly
mphocytes at time 1) and later decreased (median, 99 copies at time 2, and
27 copies at time 3), Corresponding antibody titers were low at time 1 (1 :
2154), had significantly increased by time 2 (1 : 12312), and were stable b
y time 3 (1 :4694), These viral markers were significantly lower in asympto
matic carriers than in HAM/TSP or ATL patients. Therefore, proviral load an
d antibody titers may be useful as predictive markers of disease among carr
iers.